Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael Hoebartner , Philipp Kiefer , Michael Andrew Borger , et al Added: 3 years ago
Mitral valve regurgitation (MR) is frequently induced by degenerative mitral valve (MV) disease and leads to leaflet prolapse. Therefore, valve repair is a well-proven surgical technique with excellent long-term outcomes.1–5 The risk of declining left ventricle (LV) function or LV enlargement and the development of atrial fibrillation or severe pulmonary hypertension due to chronic volume… View more
Job title: Specialist in cardiac surgery
Specialist in cardiac surgery since 2014, Dr Maurizio Taramasso has completed his surgical training at the San Raffaele University Hospital in Milan, Italy. He has also done specific cross-training in interventional cardiology and heart valve transcatheter therapies (mitral and aortic) at the San Raffaele University Hospital. His main areas of interest include surgical and catheter treatments of… View more
Author(s): Patricia Fonseca , Raphael Rosenhek , Vinayak Bapat , et al Added: 3 years ago
Degenerative aortic stenosis (AS) is a chronic progressive valvular disease that affects approximately 1.4 % of individuals over 65 years and 4.6 % of patients older than 75 years in the US.1 While the prognosis of asymptomatic patients with severe AS is generally good, that of symptomatic patients is very poor, with an overall mortality of approximately 80 % at three years once the disease… View more
Author(s): Martijn WA van Geldorp , Johanna JM Takkenberg , Ad JJC Bogers , et al Added: 3 years ago
Prevalence and Causes Degenerative aortic stenosis is the most common valvular heart disease in developed countries. Degeneration results from an active process over decades in a tricuspid or bicuspid valve, leading from mild sclerosis to calcific stenosis. It is characterised by lipid accumulation, inflammation, calcification and even bone formation, and has many similarities to atherosclerosis… View more
Author(s): Maxime Teisseire , Jérôme Caudron , Jean-Nicolas Dacher Added: 3 years ago
In patients with severe aortic stenosis (aortic valve area <1cm2 or <0.6cm2/m2) and high surgical risk (haemodynamic instability or significant co-morbidities), surgical aortic valve replacement is often rejected and, unfortunately, balloon valvuloplasty cannot provide a sustained improvement. Percutaneous heart valve (PHV) implantation is an excellent alternative treatment in such cases… View more
Foreword

Article

Added: 3 years ago
Medical advances and new technologies have allowed us to fight, with growing success, cardiovascular diseases in an increasing elderly population with higher levels of co-morbidities. Accordingly, the number of patients undergoing cardiac surgery and invasive cardiological procedures will further increase in the near future. From a cardiothoracic anaesthesiologist’s point of view, the primary… View more
Author(s): Firas Zahr Added: 2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral… View more
Author(s): Dominik Wiedemann , Thomas Haberl , Julia Riebandt , et al Added: 3 years ago
History of Mechanical Circulatory Support The first reported clinical use of a left ventricular assist device (LVAD) was by Liotta and Crawford in 1963. Via a left thoracotomy, an intracorporeal pneumatically driven pump was implanted using left atrial inflow and descending thoracic aortic outflow. Despite the successful implantation, the patient died within a short period of time after the… View more
Author(s): Matti Adam Added: 1 year ago
In this short interview, Dr Matti Adam (University Hospital Cologne, DE) outlines the findings of the ALIGN-AS EFS trial (NCT02732691). This study aimed to evaluate the clinical efficacy of the JenaValve TAVR System in patients with severe aortic stenosis. The findings show a 100% procedural success rate. Discussion points: 1. Aim of This Study 2. JenaValve TAVR System 3. Study Design and… View more
Author(s): Kendra J Grubb Added: 5 months ago
TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice. Trials covered in detail include: PARTNER 3 & EVOLUT Low-Risk ALIGN-AR TENDYNE APOLLO TRILUMINATE Recorded remotely… View more